000 | 01676 a2200469 4500 | ||
---|---|---|---|
005 | 20250513074536.0 | ||
264 | 0 | _c19930224 | |
008 | 199302s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI116196 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCantin, A | |
245 | 0 | 0 |
_aProtection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cJan 1993 |
||
300 |
_a38-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aCatalase _xpharmacology |
650 | 0 | 4 | _aCats |
650 | 0 | 4 |
_aCeftazidime _xpharmacology |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEpithelial Cells |
650 | 0 | 4 |
_aEpithelium _xdrug effects |
650 | 0 | 4 |
_aGentamicins _xpharmacology |
650 | 0 | 4 |
_aGlutathione _xpharmacology |
650 | 0 | 4 |
_aGranulocytes _xenzymology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xblood |
650 | 0 | 4 | _aLung |
650 | 0 | 4 |
_aMethionine _xpharmacology |
650 | 0 | 4 |
_aPeroxidase _xblood |
650 | 0 | 4 |
_aSodium Hypochlorite _xpharmacology |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aTicarcillin _xpharmacology |
650 | 0 | 4 |
_aTobramycin _xpharmacology |
700 | 1 | _aWoods, D E | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 91 _gno. 1 _gp. 38-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI116196 _zAvailable from publisher's website |
999 |
_c8380087 _d8380087 |